June 18th-21th, 2012
This event drew about 16 500 industry leaders from 49 states and 65 countries. Ciloa presented to pharmaceuticals and biotechnologies companies its technology for producing membrane protein on exosomes.
This technology allows producing fully native GPCRs, Ion Channel complex, Kinase Receptors and more, out of cells and allows also unlocking several bottleneck steps in the development of therapeutic monoclonal antibodies.
Presentation Flyer: Flyer Ciloa June 2012